GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.120
-0.140 (-6.19%)
At close: Oct 22, 2025, 4:00 PM EDT
2.140
+0.020 (0.94%)
After-hours: Oct 22, 2025, 7:11 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $5.33 million as of October 22, 2025. Its market cap has increased by 408.77% in one year.
Market Cap
5.33M
Enterprise Value
4.61K
1-Year Change
408.77%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.38M to $5.33M, a decrease of -78.99%. That is a compound annual growth rate of -46.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 5.68M | -23.19% |
| Dec 31, 2024 | 7.40M | 325.43% |
| Dec 29, 2023 | 1.74M | -93.15% |
| Apr 24, 2023 | 25.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |